المؤلفون: Athénaïs Boucly, Laurent Savale, Olivier Sitbon, Marc Humbert, Marie-Camille Chaumais, Gérald Simonneau, David Montani, Xavier Jaïs, Christophe Guignabert

المساهمون: Hypertension arterielle pulmonaire physiopathologie et innovation thérapeutique, Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre chirurgical Marie Lannelongue, Hôpital Antoine Béclère, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11), Université Paris-Sud - Paris 11 (UP11), Centre de Référence de l’Hypertension Pulmonaire Sévère [CHU Le Kremlin Bicêtre], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), Service de Pneumologie et Réanimation Respiratoire [AP-HP Hôpital Bicêtre] (DHU TORINO), AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre)-Centre de Référence de l'Hypertension Pulmonaire Sévère, Centre Chirurgical Marie Lannelongue (CCML)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Guignabert, Christophe, Centre chirurgical Marie Lannelongue-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: American Journal of Cardiovascular Drugs
American Journal of Cardiovascular Drugs, Springer Verlag, 2015, 15 (1), pp.13-26. ⟨10.1007/s40256-014-0095-y⟩

مصطلحات موضوعية: Vasculitis, medicine.medical_specialty, Pulmonary Circulation, Endothelium, medicine.drug_class, Hypertension, Pulmonary, [SDV]Life Sciences [q-bio], [SDV.BC]Life Sciences [q-bio]/Cellular Biology, Pharmacology, Pulmonary arterial hypertension, Models, Biological, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, Muscle, Smooth, Vascular, Endothelin, law.invention, Pathogenesis, Pharmacotherapy, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, law, Internal medicine, Medicine, Animals, Humans, Pharmacology (medical), Drug Interactions, Endothelial dysfunction, Antihypertensive drug, [SDV.BC] Life Sciences [q-bio]/Cellular Biology, Antihypertensive Agents, Clinical pharmacology, business.industry, Cell growth, Endothelins, General Medicine, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, [SDV] Life Sciences [q-bio], Endothelin receptor antagonists, Endocrinology, medicine.anatomical_structure, Practice Guidelines as Topic, Vascular resistance, [SDV.MHEP.PSR] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, Drug Therapy, Combination, Endothelium, Vascular, Cardiology and Cardiovascular Medicine, business, Endothelin receptor, Signal Transduction

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bea6ebbda559db7cadc3c6a8bf206bcTest
https://www.hal.inserm.fr/inserm-03224640Test

المؤلفون: Gérald Simonneau, Dermot S. O'Callaghan, Xavier Jaïs, Olivier Sitbon, Marc Humbert, Delphine Natali, David Montani, Florence Parent, Azzedine Yaici, Laurent Savale

المصدر: Expert opinion on pharmacotherapy. 12(10)

مصطلحات موضوعية: Ambrisentan, Endothelin A Receptor Antagonists, Hypertension, Pulmonary, Pharmacology, Mediator, Medicine, Animals, Humans, Pharmacology (medical), Receptor, Antihypertensive Agents, Sulfonamides, Phenylpropionates, Endothelin receptor antagonist, business.industry, Bosentan, General Medicine, Pathophysiology, Endothelin B Receptor Antagonists, Pyridazines, Endothelin receptor, business, Antagonism, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a40615e2cdbf54ac00d0c4612211170Test
https://pubmed.ncbi.nlm.nih.gov/21504371Test